---
$id: https://graph.org.ai/products/commodity/51422408
$type: Product
source: UNSPSC
code: "51422408"
title: "Deflazacort"
class: "51422400"
classTitle: "Corticosteroid pregnenediones"
family: "51420000"
familyTitle: "Corticosteroids"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Deflazacort

**UNSPSC Code**: 51422408
**Class**: [Corticosteroid pregnenediones](Corticosteroid pregnenediones.mdx)
**Family**: [Corticosteroids](../Corticosteroids.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic glucocorticoid with the molecular formula C25H31NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KR5YZ6AE4B, chemically known as 11beta,21-dihydroxy-2-methyl-5betah-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione 21-acetate but generally known as deflazacort, which bears US NIH Compound Identifier 26709. European Medicines Agency schedules Deflazacort in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06943MIG. The term DEFLAZACORT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules deflazacort in its Anatomical Therapeutic Chemical (ATC) Classification. DEFLAZACORT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deflazacort under HS 29372900 and SITC 54153. As of Q4 2014, DEFLAZACORT remains the US FDA Preferred Term for this commodity. Deflazacort bears US NLM identifiers UMLS ID C0057258 and NCI Concept Code C87230. SMILES: O1C2C(N=C1C)(C1(C(C3C(C(O)C1)C1(C(=CC(=O)C=C1)CC3)C)C2)C)C(=O)COC(=O)C.

